Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Risk Factors for Wound Leakage After Ozurdex Injection.

Panjaphongse R, Stewart JM.

Ocul Immunol Inflamm. 2015;23(5):410-1. doi: 10.3109/09273948.2014.894534. Epub 2014 Mar 21. No abstract available.

PMID:
24654953
2.

[Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].

Brunner M, Haueter I, Valmaggia C.

Klin Monbl Augenheilkd. 2013 Apr;230(4):396-400. doi: 10.1055/s-0032-1328365. Epub 2013 Apr 29. German.

PMID:
23629790
3.

Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema.

Scaramuzzi M, Querques G, Spina CL, Lattanzio R, Bandello F.

Retina. 2015 Jun;35(6):1216-22. doi: 10.1097/IAE.0000000000000443.

PMID:
25574787
4.

[Clinical efficacy of dexamethasone intravitreal implant (Ozurdex) in patients with retinal vein occlusions].

Kulagina AV, Gusarevich OG, Gusarevich AA, Lebedev PA, Baltaks AD.

Vestn Oftalmol. 2014 May-Jun;130(3):49-53. Russian.

PMID:
25098123
6.

Single perioperative subconjunctival steroid depot versus postoperative steroid eyedrops to prevent intraocular inflammation and macular edema after cataract surgery.

Dieleman M, Wubbels RJ, van Kooten-Noordzij M, de Waard PW.

J Cataract Refract Surg. 2011 Sep;37(9):1589-97. doi: 10.1016/j.jcrs.2011.03.049.

PMID:
21855759
7.

Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion.

Coscas G, Augustin A, Bandello F, de Smet MD, Lanzetta P, Staurenghi G, Parravano MC, Udaondo P, Moisseiev E, Soubrane G, Yatziv Y, Loewenstein A.

Eur J Ophthalmol. 2014 Jan-Feb;24(1):1-9. doi: 10.5301/ejo.5000376. Epub 2013 Oct 14.

8.

Effect of intravitreal injection of dexamethasone 0.7 mg (Ozurdex®) on intraocular pressure in patients with macular edema.

Mazzarella S, Mateo C, Freixes S, Burés-Jelstrup A, Rios J, Navarro R, García-Arumí J, Corcóstegui B, Arrondo E.

Ophthalmic Res. 2015;54(3):143-9. doi: 10.1159/000438759. Epub 2015 Sep 23.

PMID:
26394206
9.

Long-term outcome of an intravitreal dexamethasone implant for the treatment of noninfectious uveitic macular edema.

Habot-Wilner Z, Sorkin N, Goldenberg D, Loewenstein A, Goldstein M.

Ophthalmologica. 2014;232(2):77-82. doi: 10.1159/000362178. Epub 2014 Jul 10.

PMID:
25012541
10.

SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.

Coscas G, Coscas F, Zucchiatti I, Glacet-Bernard A, Soubrane G, Souïed E.

Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.

PMID:
21500185
11.

Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up.

Meyer LM, Schönfeld CL.

J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):560-5. doi: 10.1089/jop.2012.0253. Epub 2013 Mar 12.

PMID:
23480270
12.

Changes in choroidal thickness after intravitreal dexamethasone implant injection in retinal vein occlusion.

Lee EK, Han JM, Hyon JY, Yu HG.

Br J Ophthalmol. 2015 Nov;99(11):1543-9. doi: 10.1136/bjophthalmol-2014-306417. Epub 2015 Apr 16.

PMID:
25883084
13.

Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.

Adán A, Pelegrín L, Rey A, Llorenç V, Mesquida M, Molins B, Ríos J, Keller J.

Retina. 2013 Jul-Aug;33(7):1435-40. doi: 10.1097/IAE.0b013e31827e247b.

PMID:
23514796
15.

Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.

Kuppermann BD, Blumenkranz MS, Haller JA, Williams GA, Weinberg DV, Chou C, Whitcup SM; Dexamethasone DDS Phase II Study Group.

Arch Ophthalmol. 2007 Mar;125(3):309-17.

PMID:
17353400
16.

Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema.

Guigou S, Pommier S, Meyer F, Hajjar C, Merite PY, Parrat E, Rouhette H, Rebollo O, Matonti F.

Ophthalmologica. 2015;233(3-4):169-75. doi: 10.1159/000381356. Epub 2015 Apr 22.

PMID:
25924737
17.

Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.

Mayer WJ, Remy M, Wolf A, Kook D, Kampik A, Ulbig M, Reznicek L, Haritoglou C.

Ophthalmologica. 2012;228(2):110-6. doi: 10.1159/000338732. Epub 2012 Jun 23.

PMID:
22739239
18.

Intravitreal dexamethasone implant for macular edema secondary to retinal vein occlusion: 12-month follow-up and prognostic factors.

Maggio E, Polito A, Guerriero M, Pertile G.

Ophthalmologica. 2014;232(4):207-15. doi: 10.1159/000364956. Epub 2014 Nov 28.

PMID:
25471901
19.

Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.

Sella R, Oray M, Friling R, Umar L, Tugal-Tutkun I, Kramer M.

Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1777-82. doi: 10.1007/s00417-015-3124-x. Epub 2015 Jul 31.

PMID:
26228441
20.

EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.

Khurana RN, Porco TC.

Retina. 2015 Aug;35(8):1640-6. doi: 10.1097/IAE.0000000000000515.

PMID:
25741813

Supplemental Content

Support Center